Enavate Sciences GP, LLC Q1 2025 Filing

Filed May 15, 2025

Portfolio Value

$132.7B

Holdings

6

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
IMNMIMMUNOME INC
4,768,583$32.1B24.18%
2
ZBIOZENAS BIOPHARMA INC
3,761,359$29.7B22.39%
3
SIONSIONNA THERAPEUTICS INC
2,478,030$25.9B19.53%
4
CAMPCAMP4 THERAPEUTICS CORP
3,785,802$15.1B11.41%
5
UPBUPSTREAM BIO INC
2,459,703$15.1B11.34%
6
CMPXCOMPASS THERAPEUTICS INC
7,788,150$14.8B11.15%